However, inhibiting ARG1/2 by OAT-1746 unlocks antitumor response in myeloid cells, T cells and NK cells, reduce the expression of tumor-supportive gene in TAMs, and improves the efficacy of the PD-1 checkpoint inhibition63. The gene discussed is ARG1; the disease is neoplasm.